• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在韩国,局限性前列腺癌根治性前列腺切除术后的长期肿瘤学结果:10 年随访。

Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korea.

机构信息

Hospital Medicine Center, Division of Urology, Seoul National University Hospital, Seoul, Korea.

Department of Urology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Investig Clin Urol. 2020 May;61(3):269-276. doi: 10.4111/icu.2020.61.3.269. Epub 2020 Apr 21.

DOI:10.4111/icu.2020.61.3.269
PMID:32377602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7189112/
Abstract

PURPOSE

The clinical behavior of prostate cancer differs by race and ethnicity; however, data on the Korean population are scarce. We assessed the long-term oncologic outcomes of clinically localized prostate cancer after radical prostatectomy in Korean men.

MATERIALS AND METHODS

We analyzed 786 clinically localized prostate cancer patients who underwent radical prostatectomy, from June 1993 to June 2008. Kaplan-Meier survival curve analysis and log-rank test were used to assess the oncologic outcomes.

RESULTS

The mean age of the patients was 64.9±6.6 years. Pelvic lymph node dissection was performed in 373 patients. Pathologic T and N stage cancer with local advancement and invasion were detected by radical prostatectomy in 307 and 22 patients, respectively. In total, 38 patients who underwent adjuvant therapy were excluded from the analysis of progression after biochemical recurrence (BCR), which occurred in 261 men. In total, 219 patients underwent salvage treatment. Local recurrence and distant metastasis occurred in 109 and 42 patients, respectively; 36 patients experienced metastasis with local recurrence. Castration-resistant prostate cancer developed in 22 patients, and overall and disease-specific mortality was noted in 148 and 23 patients, respectively. The median duration from operation to BCR, BCR to metastasis, and metastasis to disease-specific death was 25, 40, and 22 months, respectively.

CONCLUSIONS

We demonstrated the long-term prognosis of localized prostate cancer after radical prostatectomy among Koreans. Our results differ from those reported in the Western literature, with a lower prevalence of distant metastasis and shorter time to metastasis after BCR.

摘要

目的

前列腺癌的临床行为因种族和民族而异;然而,有关韩国人群的数据却很少。我们评估了韩国男性根治性前列腺切除术后局限性前列腺癌的长期肿瘤学结果。

材料和方法

我们分析了 1993 年 6 月至 2008 年 6 月期间接受根治性前列腺切除术的 786 例局限性前列腺癌患者。使用 Kaplan-Meier 生存曲线分析和对数秩检验评估肿瘤学结果。

结果

患者的平均年龄为 64.9±6.6 岁。373 例患者行盆腔淋巴结清扫术。通过根治性前列腺切除术检测到局部进展和侵犯的病理 T 和 N 期癌症分别为 307 例和 22 例。共有 38 例接受辅助治疗的患者被排除在生化复发(BCR)后的进展分析之外,261 例男性发生了 BCR。共有 219 例患者接受了挽救性治疗。109 例患者发生局部复发,42 例患者发生远处转移;36 例患者发生局部复发和转移。22 例患者发生去势抵抗性前列腺癌,148 例患者发生总死亡率,23 例患者发生疾病特异性死亡率。从手术到 BCR、BCR 到转移以及转移到疾病特异性死亡的中位时间分别为 25、40 和 22 个月。

结论

我们展示了韩国男性根治性前列腺切除术后局限性前列腺癌的长期预后。我们的结果与西方文献报道的结果不同,远处转移的发生率较低,BCR 后转移的时间也较短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/7189112/106bc9efba7f/icu-61-269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/7189112/e3d67f19a668/icu-61-269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/7189112/106bc9efba7f/icu-61-269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/7189112/e3d67f19a668/icu-61-269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3964/7189112/106bc9efba7f/icu-61-269-g002.jpg

相似文献

1
Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korea.在韩国,局限性前列腺癌根治性前列腺切除术后的长期肿瘤学结果:10 年随访。
Investig Clin Urol. 2020 May;61(3):269-276. doi: 10.4111/icu.2020.61.3.269. Epub 2020 Apr 21.
2
Oncologic outcomes at 10 years following robotic radical prostatectomy.机器人辅助根治性前列腺切除术 10 年后的肿瘤学结果。
Eur Urol. 2015 Jun;67(6):1168-1176. doi: 10.1016/j.eururo.2014.06.025. Epub 2014 Jul 2.
3
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.吸烟与生化疾病复发、转移、去势抵抗性前列腺癌以及根治性前列腺切除术后的死亡率增加相关:来自 SEARCH 数据库的结果。
Cancer. 2014 Jan 15;120(2):197-204. doi: 10.1002/cncr.28423. Epub 2013 Oct 11.
4
Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.在前列腺特异性抗原时代,对pT3bN0M0前列腺癌行根治性前列腺切除术及双侧盆腔淋巴结清扫术后的长期癌症控制。
Urol Oncol. 2014 Feb;32(2):85-91. doi: 10.1016/j.urolonc.2013.03.005. Epub 2013 Oct 30.
5
Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.种族与临床局限性前列腺癌根治性前列腺切除术后肿瘤学结果的关系:一项长期随访研究。
World J Urol. 2018 Aug;36(8):1233-1239. doi: 10.1007/s00345-018-2266-y. Epub 2018 Mar 13.
6
Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.根治性前列腺切除术对接受去势治疗的病理性淋巴结阳性前列腺癌患者长期肿瘤学结局的影响:一项匹配队列研究。
J Urol. 2017 Jul;198(1):86-91. doi: 10.1016/j.juro.2017.01.063. Epub 2017 Jan 24.
7
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.扩展盆腔淋巴结清扫术对接受根治性前列腺切除术治疗的 D'Amico 中高危前列腺癌患者肿瘤学结局的影响:一项多机构研究。
J Urol. 2020 Feb;203(2):338-343. doi: 10.1097/JU.0000000000000504. Epub 2019 Aug 22.
8
Does the Time Interval from Biopsy to Radical Prostatectomy Affect the Postoperative Oncologic Outcomes in Korean Men?从前列腺活检到根治性前列腺切除术的时间间隔是否会影响韩国男性的术后肿瘤学结果?
J Korean Med Sci. 2019 Sep 30;34(37):e234. doi: 10.3346/jkms.2019.34.e234.
9
Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years.对一系列临床局限性前列腺癌患者进行腹腔镜根治性前列腺切除术后,经过10年的中位随访得出的长期肿瘤学结果。
Clin Genitourin Cancer. 2016 Aug;14(4):290-7. doi: 10.1016/j.clgc.2015.11.006. Epub 2015 Nov 17.
10
Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.寡转移前列腺癌男性行根治性前列腺切除术:单中心系列长期随访结果。
Eur Urol. 2017 Aug;72(2):289-292. doi: 10.1016/j.eururo.2016.08.040. Epub 2016 Aug 27.

引用本文的文献

1
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer.雄激素剥夺疗法联合阿比特龙/泼尼松与雄激素剥夺疗法联合多西他赛治疗转移性激素敏感性前列腺癌患者的短期疗效和安全性比较
World J Mens Health. 2024 Jul;42(3):620-629. doi: 10.5534/wjmh.230104. Epub 2024 Jan 2.
2
Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy.挽救性再放疗用于低剂量初步近距离放射治疗后复发的前列腺癌。
Clin Transl Oncol. 2024 Apr;26(4):872-879. doi: 10.1007/s12094-023-03315-1. Epub 2023 Sep 6.
3

本文引用的文献

1
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议:分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
2
The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis.诊断时年龄对前列腺癌死亡率的影响:分级和分期分析
Eur J Surg Oncol. 2014 Dec;40(12):1706-15. doi: 10.1016/j.ejso.2014.05.001. Epub 2014 May 22.
3
Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China.
中国 20 年单机构局限性前列腺癌根治性前列腺切除术的结果。
Asian J Androl. 2023 May-Jun;25(3):345-349. doi: 10.4103/aja202264.
4
Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.联合使用 JNK 抑制剂和肝细胞生长因子治疗海绵体神经损伤大鼠模型的勃起功能:与单独使用 JNK 抑制剂或肝细胞生长因子的比较。
Int J Mol Sci. 2021 Nov 24;22(23):12698. doi: 10.3390/ijms222312698.
Current role of surgery for high risk prostate cancer.
Arch Esp Urol. 2013 Apr;66(3):259-73, 259-74.
4
Natural history of early, localized prostate cancer: a final report from three decades of follow-up.早期局限性前列腺癌自然史:三十余年随访的最终报告。
Eur Urol. 2013 Mar;63(3):428-35. doi: 10.1016/j.eururo.2012.10.002. Epub 2012 Oct 13.
5
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.根治性前列腺切除术治疗 cT3 前列腺癌 20 年生存。
BJU Int. 2012 Dec;110(11):1709-13. doi: 10.1111/j.1464-410X.2012.11372.x. Epub 2012 Aug 30.
6
Radical prostatectomy versus watchful waiting in early prostate cancer.根治性前列腺切除术与早期前列腺癌的观察等待。
N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.
7
Impact of age at diagnosis on prostate cancer treatment and survival.诊断时年龄对前列腺癌治疗和生存的影响。
J Clin Oncol. 2011 Jan 10;29(2):235-41. doi: 10.1200/JCO.2010.30.2075. Epub 2010 Dec 6.
8
Time trends and local variation in primary treatment of localized prostate cancer.局限性前列腺癌的主要治疗方法的时间趋势和局部变化。
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
9
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.在前列腺特异性抗原时代接受治疗的患者,根治性前列腺切除术后的前列腺癌特异性死亡率。
J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.
10
Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience.腹腔镜根治性前列腺切除术后的肿瘤学结局:10年经验
Eur Urol. 2009 May;55(5):1014-9. doi: 10.1016/j.eururo.2008.10.036. Epub 2008 Nov 6.